ZB3-20371-66075
4 vaccinations
5 coded responses
39 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 547 / WI
- Registered
- 2020-12-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
WSD-27852-01642
Child or adolescent in my care · Male · 2022-07-07
FAB-22362-20040
Child or adolescent in my care · Female · 2022-08-25
Timeline
-
2020-12-28
Registered in v-safe
-
2020-12-28
Dose 1 — Pfizer-BioNTech
- 2020-12-28
- 2020-12-29
- 2020-12-30
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-06
- 2021-01-12
-
2021-01-18
Dose 2 — Pfizer-BioNTech
- 2021-02-01
- 2021-02-08
- 2021-02-15
- 2021-02-22
- 2021-03-03
-
2021-04-21
Survey response — 3 months, dose 2MedDRA: Nasal congestion, Nasopharyngitis, Rhinorrhoea, SARS-CoV-2 test negative — Feeling: Good · Be unable to workFree text: Typical cold with nasal congestion, runny nose but COVID test was negative.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-19
Survey response — 6 months, dose 2MedDRA: Gastroenteritis viral, Nasopharyngitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Stomach flu, typical colds. Negative swabs for all.MedDRA releases: 2024-11 · check-in free text available
-
2021-09-26
Dose 3 — Pfizer-BioNTech
- 2021-09-30
- 2021-10-01
- 2021-10-02
- 2021-10-03
-
2021-10-10
Survey response — day 14, dose 3MedDRA: Cough, Fatigue, Nasal congestion — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Nasal congestion, cough, fatigueMedDRA releases: 2024-11 · check-in free text available
- 2021-10-17
- 2021-10-24
- 2021-11-02
- 2021-11-07
-
2021-12-26
Survey response — 3 months, dose 3MedDRA: Cough, Nasal congestion — Feeling: GoodFree text: Nasal congestion, coughMedDRA releases: 2024-11 · check-in free text available
-
2022-09-23
Dose 4 — Pfizer-BioNTech
- 2022-09-24
- 2022-09-25
- 2022-09-26
- 2022-09-27
- 2022-09-28
- 2022-09-29
- 2022-09-30
- 2022-10-07
-
2022-10-14
Survey response — day 21, dose 4MedDRA: Nasal congestion, Nasopharyngitis, Rhinorrhoea — Feeling: FairFree text: Typical cold with runny nose and nasal congestion.MedDRA releases: 2024-11 · check-in free text available
- 2022-10-21
- 2022-10-28
- 2022-11-04
- 2022-12-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-28 | Pfizer-BioNTech | |
| 2 | 2021-01-18 | Pfizer-BioNTech | |
| 3 | 2021-09-26 | Pfizer-BioNTech | No |
| 4 | 2022-09-23 | Pfizer-BioNTech | No |
Free text
Release 7 — 3 months, dose 2
Symptoms: Typical cold with nasal congestion, runny nose but COVID test was negative.
Release 9 — 6 months, dose 2
Symptoms: Stomach flu, typical colds. Negative swabs for all.
Release 10 — day 14, dose 3
Symptoms: Nasal congestion, cough, fatigue
Release 10 — 3 months, dose 3
Symptoms: Nasal congestion, cough
Release 12 — day 21, dose 4
Symptoms: Typical cold with runny nose and nasal congestion.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Gastroenteritis viral | · | · | ✓ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release